Susquehanna Fundamental Investments’s Eton Pharmaceutcials ETON Stock Holding History

Susquehanna Fundamental Investments’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$93K	Sell	21,269 -7,292	-26%	-$28.7K	﹤0.01%	1457
2021 Q4	$123K	Sell	28,561 -2,283	-7%	-$10.9K	﹤0.01%	1315
2021 Q3	$155K	Buy	+30,844	New	+$160K	﹤0.01%	1575

Other funds holding ETON

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna Fundamental Investments's ETON Position: Q1 2022 in Review

Susquehanna Fundamental Investments reduced its Eton Pharmaceutcials (ETON) stake by 26% in Q1 2022, selling an estimated $28.7K and leaving 21,269 shares worth $93K. The position accounts for ﹤0.01% of the portfolio, ranked #1457.

Susquehanna Fundamental Investments first reported a position in ETON in Q3 2021 and has held it in 3 quarters since. The position peaked at $155K in Q3 2021. 31 funds tracked by Wall St. Rank hold ETON as of Q1 2022.

Susquehanna Fundamental Investments held 21,269 shares of Eton Pharmaceutcials worth $93K as of Q1 2022.
Susquehanna Fundamental Investments sold 7,292 Eton Pharmaceutcials shares in Q1 2022, an estimated $28.7K.
Eton Pharmaceutcials made up ﹤0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1457 holding.
Susquehanna Fundamental Investments first reported a position in Eton Pharmaceutcials in Q3 2021 and has held it in 3 quarters since.
Susquehanna Fundamental Investments's Eton Pharmaceutcials position peaked at $155K in Q3 2021.
31 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.